The early days of the US International Development Finance Corporation (DFC) have been defined by a mixed record, and its health-focused investments are no exception. In the face of competing foreign (and even domestic) policy priorities under the Trump Administration and pandemic-related shifts in the broader development landscape, the agency has struggled to build a solid pipeline of projects in lower-income markets and systematically articulate a strong development rationale for its financing.
CGD Policy Blogs
The UK Aid Cuts to UNFPA: Ripple Effects in Sexual and Reproductive Health Product Markets with Outsized Impacts for Women and Girls
The UN Population Fund (UNFPA) recently revealed that the UK government intends to cut aid to its supplies program by 85 percent, slashing Britain’s original 2021 commitment from $211 million to $32 million.
COVID-19 Vaccination and the Multilateral Development Banks: Moving Towards a More Systematic and Strategic Approach
How should the MDB vaccine effort intersect with global efforts like COVAX, or indeed plans to share or donate vaccine amongst countries? In this blog, we look at two issues raised by the World Bank’s approach so far and offer options for a better way forward.
Getting Back on Track: How to Advance the Biden-Harris Administration’s Early Actions on Women’s Health
Here are four additional policy priorities for the Biden-Harris administration’s to-do list.
If governments of LMICs reformed their medicines procurement practices, how much money would they be able to save? And how much further towards universal health coverage would these savings enable them to go?
COVID-19 Surfaces New Directions for Old Challenges: Three Lasting Ways to Improve Global Health Procurement
Effective and efficient procurement of health products—medicines, diagnostics, and devices—is a critical function of all strong health systems. The pandemic has exacerbated long-standing challenges—as highlighted by a recent CGD Working Group—in the purchasing of both COVID-related emergency supplies and other essential health products.
Inclusive policy changes spurred by COVID-19 have so far been limited and temporary, but as governments chart a path to recovery, immigrants and citizens alike would benefit from their extension well beyond the pandemic. This blog highlights two areas—access to the labor market and healthcare—where pandemic-related inclusive responses for immigrants should continue, expand, and pave the way for long-run positive change.
As low- and middle-income countries are hit by the health and economic effects of COVID-19, the international community is working to mobilize billions of dollars in grants, loans, and debt relief. At the moment, it is difficult to get a full picture of the funding on offer, to whom it is given, and how it will be used.
Examining Uncertainties in Global Health Aid through the Lens of Family Planning: A Tale of Three Countries in Three Figures
In the months before the current crisis, CGD’s global health policy team partnered with Pharos Global Health Advisors to understand competing fiscal and programmatic pressures across the health sector. It aimed to drill down on challenges, risks, and opportunities associated with transitions from different global health financing mechanisms.